Avadomide
An investigational drug for cancer treatment
| Avadomide | |
|---|---|
| |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Avadomide is an investigational drug that is being studied for its potential use in the treatment of various types of cancer. It belongs to a class of drugs known as immunomodulatory drugs (IMiDs), which are designed to modulate the immune system to enhance the body's ability to fight cancer.
Mechanism of Action[edit | edit source]
Avadomide works by modulating the activity of the cereblon protein, which is a component of the ubiquitin ligase complex. This modulation leads to the degradation of specific proteins that are involved in the proliferation and survival of cancer cells. By targeting these proteins, avadomide can induce apoptosis in cancer cells and inhibit their growth.
Clinical Development[edit | edit source]
Avadomide is currently undergoing clinical trials to evaluate its efficacy and safety in treating various hematological malignancies, including multiple myeloma and non-Hodgkin lymphoma. These trials are designed to assess the drug's ability to improve patient outcomes when used alone or in combination with other therapies.
Potential Benefits[edit | edit source]
The potential benefits of avadomide include its ability to selectively target cancer cells while sparing normal cells, which may result in fewer side effects compared to traditional chemotherapy. Additionally, as an oral medication, avadomide offers a convenient administration route for patients.
Side Effects[edit | edit source]
As with many investigational drugs, avadomide may cause side effects. Commonly reported side effects in clinical trials include fatigue, nausea, and anemia. The safety profile of avadomide continues to be evaluated in ongoing studies.
Research and Future Directions[edit | edit source]
Research on avadomide is focused on understanding its full potential in cancer therapy, including its use in combination with other treatments such as monoclonal antibodies and checkpoint inhibitors. Future studies may explore its application in other types of cancer and its long-term effects on patient survival and quality of life.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
